A Study of Mitoxantrone Hydrochloride Liposome Injection for Relapsing Multiple Sclerosis
Clinical trial NCT05496894 · WITHDRAWN
Trial details
- NCT number
- NCT05496894
- Sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2022-11-08
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.